Rates of growth of human neoplasms: Part II

Journal of Surgical Oncology

Volumn 61, Issue 1, 1996, Pages 68-83

  Spratt, John S ^a,d   Meyer, John S ^b   Spratt, John A ^c  

^a University of Louisville School of Medicine   (United States)

^b ST LUKE S HOSPITAL   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

Author keywords

breast cancer; chemodectoma; growth rates; maxillary antrum; melanomas; multiple primary cancers; pulmonary cancers; pulmonary metastases; skeletal sarcomas; testicular cancers

Indexed keywords

BREAST CANCER; CANCER GROWTH; CHEMODECTOMA; HUMAN; LUNG CARCINOMA; LUNG METASTASIS; MELANOMA; MITOSIS INDEX; MITOSIS RATE; MULTIPLE CANCER; MYOSARCOMA; PRIORITY JOURNAL; REVIEW; TESTIS CANCER;

BONE NEOPLASMS; BREAST NEOPLASMS; CELL DIVISION; FEMALE; HUMANS; LOGISTIC MODELS; LUNG NEOPLASMS; MALE; MELANOMA; NEOPLASMS, MULTIPLE PRIMARY; PARAGANGLIOMA, EXTRA-ADRENAL; PROSTATIC NEOPLASMS; RADIOGRAPHY, THORACIC; REGRESSION ANALYSIS; SARCOMA; SURVIVAL RATE; TESTICULAR NEOPLASMS;

EID: 0030046467     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-9098(199601)61:1<68::AID-JSO2930610102>3.0.CO;2-E     Document Type: Review

References (69)

1. Spratt JS, Spratt TL: Rates of growth of pulmonary metastases and host survival. Ann Surg 159:161-171, 1964.
2. Spratt JS Jr, Spjut HJ, Ter-Pogossian M, Roper CL: Correlation of primary pulmonary neoplastic growth curves with morphology, necrosis, survival and aetiology [Abstract]. "Proceedings of the VIIIth International Cancer Congress, Moscow, USSR." 1962, p 281.
3. Spratt JS Jr, Spjut HJ, Roper CL: The frequency distribution of the rates of growth and the estimated duration of primary pulmonary carcinoma. Cancer 16:687-693, 1963.
4. Spratt JS Jr, Spjut HJ, Roper CL: The frequency distribution of the growth rates and the estimated duration of primary pulmonary carcinomas. Extrait De Acta Union Internationale Contre Le Cancer 19:1270-1275, 1963.
5. Spratt JS Jr, Ter-Pogossian M, Long RTL: The detection and growth of intrathoracic neoplasms. Arch Surg 86:183-288, 1963.
6. Spector GW, Roper CL, Spratt JS Jr: Chemodectoma of the mediastinum. Arch Surg 87:903-906, 1963.
7. Spratt JS Jr, Spratt JA: The prognostic value of measuring the gross linear radial growth of pulmonary metastases and primary pulmonary cancers. J Thorac Cardiovasc Surg 71:274-278, 1976.
8. Spratt JS: The lognormal frequency distribution and human cancer. J Surg Res 9:151-157, 1969.
9. Bean WB: Nail growth: 30 years of observation. Arch Intern Med 134:497-502, 1974.
10. Kusama S, Spratt JS, Donegan WL, et al.: The gross rates of growth of human mammary carcinoma. Cancer 30:594-599, 1972.
11. Spratt JS, Kaltenbach ML, Spratt JA: Cytokinetic definition of acute and chronic breast cancer. Cancer Res 37:226-230, 1977.
12. Pearlman AW: Breast cancer - Influence of growth rate on prognosis and treatment evaluation. A study based on mastectomy scar recurrences. Cancer 38:1826-1833, 1976.
13. Baker LH: Breast cancer detection demonstration project. Five year summary report. CA 32:194-225, 1982.
14. Heuser L, Spratt JS, Polk HC Jr, Buchanan J: Relation between mammary cancer growth kinetics and the intervals between screening. Cancer 43:857-862, 1979.
15. Spratt JS: The relationship between the rates of growth and the interval between screening examinations necessary for effective discovery. Cancer Detec Prev 4:301-305, 1981.
16. Heuser L, Spratt JS, Polk HC Jr: Growth rates of primary mammary cancer. Cancer 43:1888-1893, 1979.
17. Spratt JS, Kuhns JG, Reiman HM, et al.: Association between the growth rates of primary mammary cancer, histopathological characteristics, and Wolfe's parenchymal mammographic patterns. Int J Radiat Oncol Biol Phys 6(Suppl 1):27-28, 1979.
18. Spratt JS, Heuser L, Kuhns JG, et al.: Association between actual doubling times of primary breast cancer with histopathologic characteristics and Wolfe's parenchymal mammographic patterns. Cancer 47:2265-2268, 1981.
19. Spratt JS, Heuser S, Kuhns JG, et al.: Variations and associations in histopathology, clinical factors, mammographic patterns and growth rates among breast cancers confirmed in a screened population. In Mettlin C, Murphy GP (eds): "Issues in Cancer Screening Communications." New York: Alan R. Liss, Inc., 1982: pp 295-299.
20. Buchanan JB, Spratt JS, Heuser LS: Tumor growth, doubling times and the inability of the radiologist to diagnose certain cancers. Radiol Clin North Am 21:115-126, 1983.
21. Spratt JS, Chang AFC, Heuser LS, et al.: Acute carcinoma of the breast. Surg Gynecol Obstet 157:220-222, 1983.
22. Heuser LS, Spratt JS, Kuhns JG, et al.: The association of pathologic and mammographic characteristics of primary human breast cancers with "slow" and "fast" growth rates and with axillary lymph node metastases. Cancer 53:96-98, 1984.
23. Spratt JS: Interview: The fast growing breast carcinoma. Emerg Med 15:73-77, 1984.
24. von Fournier D, Weber E, Hoeffken W, et al.: Growth rate of 147 mammary carcinomas. Cancer 45:2198-2207, 1980.
25. Spratt JS, Alagia DP, Greenberg RA, et al.: Association of chronic cystic mastopathy, xeromammographic patterns and cancer Cancer 55:1372-1375, 1985.
26. Spratt JS, Greenberg RA, Heuser LS: Geometry, growth rates, and duration of cancer and carcinoma in situ of the breast before detection by screening Cancer Res 46:970-974, 1986.
27. Gompertz B: On the nature of the function expressive of the law of human mortality, and on a new mode of determining the value of life contingencies. Philos Trans R Soc Lond [Biol] 115:513-583, 1825.
28. Skehan P: Cell growth, tissue neogenesis and neoplastic formation. In Skehan P, Friedman SJ (eds): "Growth, Cancer and the Cell Cycle." Clifton, NJ: The Humana Press, 1984, pp 323-345.
29. Meyer JS, Prey MU, Babcock DS, McDivitt RW: Breast carcinoma cell kinetics, morphology, stage and host characteristics. A thymidine labeling study. Lab Invest 54:41-51, 1986.
30. Meyer JS, Koehm SL, Hughes JM, et al.: Bromodeoxyuridine labeling for S-phase measurement in breast carcinoma. Cancer 71:3631-3640, 1993.
31. Goldie JH, Coldman AJ: A model for tumor response to chemotherapy; an integration of the stem cell hypothesis of somatic mutation. Cancer Invest 5:553-564, 1985.
32. Rashevsky N: "Mathematical Biophysics; Physiocochemical Foundation of Biology, 3rd ed." New York: Dover Publications, 1960.
33. Spratt JA, von Fournier D, Spratt JS, Weber EE: Decelerating growth and human breast cancer [Abstract]. Cell Tissue Kinet 21:556, 1988.
34. Spratt JA, von Fournier D, Spratt JS, Weber EE: Mammographic assessment of human breast cancer growth and duration. Cancer 71:2020-2026, 1993.
35. Spratt JA, von Fournier D, Spratt JS, Weber EE: Decelerating growth and human breast cancer. Cancer 71:2014-2019, 1993.
36. Verlust PF: Notice sur la loi que la population suit dan so accroissement. Correspondence Math Phys l'obsevatoire Bruxelle 10:113-121, 1838.
37. Cooke KL, Witten M: One-dimensional linear and logistic harvesting models. Math Model 7:301-340, 1986.
38. Goel NS, Richter-Dyn N: "Stochastic Models in Biology." New York: Academic Press, 1974; pp 73-75.
39. Neider JA: The fitting of a generalization of the logistic curve. Biometrics 17:89-110, 1961.
40. Tubiana M, Pejovic MJ, Renaud A, et al.: Kinetic parameters and the course of disease in breast cancer. Cancer 47:937-943, 1981.
41. Brunton GF, Wheldon TE: The Gompertz equation and the construction of tumor growth curves. Cell Tissue Kinet 13:455-460, 1980.
42. Brunton GF, Wheldon TE: Prediction of the complete growth pattern of human multiple myeloma from restricted initial measurements. Cell Tissue Kinet 10:591-594, 1977.
43. Wette R, Katz IN, Roding EY: Stochastic processes for solid tumor kinetics: Surface regulated growth. Math Biosci 19:231-255, 1974.
44. Speer JF, Petrosky VE, Relsky MV, Wardwell RH: A stochastic numerical model of breast cancer that stimulates clinical data. Cancer Res 44:4124-4130, 1984.
45. Norton L, Simon R, Brereton HD, Bogden AE: Predicting the course of Gompertzian growth. Nature 264:542-545, 1976.
46. Gaddum JH: Lognormal distributions. Nature 156:463-466, 1945.
47. Kusama S, Spratt JS, Donegan WL, et al.: The gross rates of growth of human mammary carcinoma. Cancer 30:594-599, 1972.
48. Lee Y-TN: The lognormal distribution of growth rates of soft tissue metastases of breast cancer. J Surg Oncol 4:81-88, 1972.
49. Bailar JC: Screening for early breast cancer: Pros and cons. Cancer 39:2783-2795, 1977.
50. Eddy DM: "Screening for Cancer: Theory, Analysis and Design." Englewood Cliffs, NJ: Prentice-Hall, 1980; pp 115-122.
51. Spratt JS: The epidemiology of screening for cancer. Curr Probl Cancer 6:3-58, 1982.
52. Baker LH: Breast cancer detection demonstration project: Five year summary report. Cancer 32:194-230, 1982.
53. Holland R, Maravunac M, Hendricks JHCL, Bekker BV: So called interval cancers of the breast: Pathologic and radiologic analysis of sixty-four cases. Cancer 49:2527-2533, 1982.
54. Heuser L, Spratt JS, Polk HC Jr: Growth rates of primary breast cancers. Cancer 43:1888-1894, 1979.
55. Spratt JS, Spratt JA: What is breast cancer doing before we can detect it? J Surg Oncol 30:156-160. 1985.
56. Spratt JS, Meyer JS, Spratt JA: Rates of growth of human solid neoplasms: Part I. J Surg Oncol 60:137-146, 1995.
57. Gasparini G, Weidner N, Bevilacqua P, et al.: Tumor microvessel density, p53 expression, tumor size and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast cancer. J Clin Oncol 12:454-466, 1994.
58. Spratt JS: The rates of growth of skeletal sarcomas. Cancer 18:14-24, 1965.
59. 3H thymidine labeling in human breast tumors. Mod Pathol 4:767-795, 1991.
60. Meyer JS, Hixon B: Advanced stage and early relapse of breast carcinomas associated with high thymidine labeling indices. Cancer Res 39:4042-4047, 1979.
61. Meyer JS, Province MA: S-phase fraction and nuclear size in long term prognosis of patients with breast cancer. Cancer 74:2287-2299, 1994.
62. White RA, Terry NHA, Baggerly KA, Meistrich ML: Measuring cell proliferation by relative movement. I. Introduction and in vitro studies. Cell Prolif 24:257-270, 1991.
63. Knutson CO, Hori JM, Spratt JS: Melanoma. Curr Problems Cancer. 1-25, 1971.
64. Spratt JS, Mercado R, Perez-Mesa C, Haun CL: Carcinoma of the maxillary antrum: Coordinated roentgen-surgical therapy. Mo Med 61:1003-1010, 1964.
65. Spratt JS, Yuen PF: Retroperitoneal lymph node dissection and resection of pulmonary metastases for testicular cancer. Mo Med 63:981-985, 1966.
66. Meyer JS, He W: Cell proliferation measurements by bromodeoxyuridine or thymidine incorporation: Clinical correlates. Semin Radiat Oncol 3:126-134, 1993.
67. Schmid HP, McNeal JE, Stamey TA: Observations on the doubling time of prostate cancer. Cancer 71:2031-2040, 1993.
68. Scrivner DL, Meyer JS, Runanavech N, et al.: Cell kinetics by bromodeoxyuridine labeling and deoxyribonucleic acid ploidy in prostatic carcinoma needle biopsies. J Urol 146:1034-1039, 1991.
69. Spratt JS, Hoag MG: Incidence of multiple primary cancers per man-year of follow-up. Ann Surg 164:775-784, 1966.